News
To demonstrate that MSN infringes the ’918 patent, Novartis compared a Raman spectrum from MSN’s abbreviated new drug application (ANDA) to a reference Raman spectrum. Raman spectroscopy is a method ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback